Capricor Therapeutics Stock Market Value
| CAPR Stock | USD 13.70 0.20 1.48% |
| Symbol | Capricor |
Capricor Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Capricor Therapeutics. If investors know Capricor will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Capricor Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share | Quarterly Revenue Growth (0.63) | Return On Assets | Return On Equity |
The market value of Capricor Therapeutics is measured differently than its book value, which is the value of Capricor that is recorded on the company's balance sheet. Investors also form their own opinion of Capricor Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Capricor Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Capricor Therapeutics' market value can be influenced by many factors that don't directly affect Capricor Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Capricor Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Capricor Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Capricor Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Capricor Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Capricor Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Capricor Therapeutics.
| 12/20/2024 |
| 01/19/2025 |
If you would invest 0.00 in Capricor Therapeutics on December 20, 2024 and sell it all today you would earn a total of 0.00 from holding Capricor Therapeutics or generate 0.0% return on investment in Capricor Therapeutics over 30 days. Capricor Therapeutics is related to or competes with Bio Path, NextCure, Pulmatrix, Akari Therapeutics, Soleno Therapeutics, Unicycive Therapeutics, and Cidara Therapeutics. Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell a... More
Capricor Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Capricor Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Capricor Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 33.27 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 9.07 |
Capricor Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Capricor Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Capricor Therapeutics' standard deviation. In reality, there are many statistical measures that can use Capricor Therapeutics historical prices to predict the future Capricor Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.38) |
Capricor Therapeutics Backtested Returns
Capricor Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0895, which signifies that the company had a -0.0895% return per unit of risk over the last 3 months. Capricor Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Capricor Therapeutics' Standard Deviation of 5.8, risk adjusted performance of (0.04), and Mean Deviation of 4.08 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.99, which signifies possible diversification benefits within a given portfolio. Capricor Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Capricor Therapeutics is expected to follow. At this point, Capricor Therapeutics has a negative expected return of -0.5%. Please make sure to confirm Capricor Therapeutics' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Capricor Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Capricor Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between Capricor Therapeutics time series from 20th of December 2024 to 4th of January 2025 and 4th of January 2025 to 19th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Capricor Therapeutics price movement. The serial correlation of -0.19 indicates that over 19.0% of current Capricor Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | -0.82 | |
| Residual Average | 0.0 | |
| Price Variance | 0.44 |
Capricor Therapeutics lagged returns against current returns
Autocorrelation, which is Capricor Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Capricor Therapeutics' stock expected returns. We can calculate the autocorrelation of Capricor Therapeutics returns to help us make a trade decision. For example, suppose you find that Capricor Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Capricor Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Capricor Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Capricor Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Capricor Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Capricor Therapeutics Lagged Returns
When evaluating Capricor Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Capricor Therapeutics stock have on its future price. Capricor Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Capricor Therapeutics autocorrelation shows the relationship between Capricor Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Capricor Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Capricor Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Capricor Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Capricor Stock
Moving against Capricor Stock
| 0.85 | DRTS | Alpha Tau Medical | PairCorr |
| 0.78 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.75 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.74 | VCYT | Veracyte Potential Growth | PairCorr |
| 0.7 | VCEL | Vericel Corp Ord | PairCorr |
The ability to find closely correlated positions to Capricor Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Capricor Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Capricor Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Capricor Therapeutics to buy it.
The correlation of Capricor Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Capricor Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Capricor Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Capricor Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.